Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
1.75M
-
Shares change
-
-19.8K
-
Total reported value, excl. options
-
$220M
-
Value change
-
-$1.78M
-
Put/Call ratio
-
0.27
-
Number of buys
-
29
-
Number of sells
-
-35
-
Price
-
$125.63
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2017
92 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q2 2017.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.75M shares
.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (1.03M shares), MORGAN STANLEY (87.7K shares), UBS Group AG (74.1K shares), ROYAL BANK OF CANADA (60.5K shares), MURPHY CAPITAL MANAGEMENT INC (47.9K shares), Endurant Capital Management LP (46K shares), Strategic Financial Services, Inc, (27K shares), BOSTON RESEARCH & MANAGEMENT INC (21.9K shares), Cambridge Investment Research Advisors, Inc. (21.6K shares), and ASPIRIANT, LLC (19.5K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.